Literature DB >> 25134360

[The role of the DNA damage response in apoptosis and cell senescence].

Zbigniew Korwek, Olga Alster.   

Abstract

The genetic material is constantly subjected to DNA damage which is caused by physiological processes occuring in the cell and is exposed to exogenous DNA damaging agents. Eucariotic cells have developed a system called the DNA damage response (DDR), which is responsible for maintaining genomic inegrity. DNA damage can lead to senescence, DNA repair as well as to cell death. The key protein in the DDR pathway is p53. This protein undergoes numerous posttranslational modifications and can be involved in the activation of many genes and proteins leading to survival or cell death. In cell senescence the p53 protein leads to the induction of p21, which causes cell cycle arrest. In apoptosis p53 participates in the activation of caspases, which are responsible for the degradation of many proteins.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25134360

Source DB:  PubMed          Journal:  Postepy Biochem        ISSN: 0032-5422


  5 in total

1.  Differential expression profile analysis of DNA damage repair genes in CD133+/CD133- colorectal cancer cells.

Authors:  Yuhong Lu; Xin Zhou; Qingliang Zeng; Daishun Liu; Changwu Yue
Journal:  Oncol Lett       Date:  2017-06-19       Impact factor: 2.967

2.  Apoptotic and DNA Damage Effect of 1,2,3,4,6-Penta-O-galloyl-beta-D-glucose in Cisplatin-Resistant Non-Small Lung Cancer Cells via Phosphorylation of H2AX, CHK2 and p53.

Authors:  Ji-Hyun Kim; Eunji Im; Jihyun Lee; Hyo-Jung Lee; Deok Yong Sim; Ji Eon Park; Chi-Hoon Ahn; Hyeon Hee Kwon; Bum Sang Shim; Bonglee Kim; Sung-Hoon Kim
Journal:  Cells       Date:  2022-04-14       Impact factor: 7.666

3.  PICT-1 is a key nucleolar sensor in DNA damage response signaling that regulates apoptosis through the RPL11-MDM2-p53 pathway.

Authors:  Hongbo Chen; Liqiao Han; Hsiangi Tsai; Zhiwei Wang; Yanping Wu; Yanhong Duo; Wei Cao; Lijun Chen; Zhirong Tan; Ning Xu; Xianzhang Huang; Junhua Zhuang; Laiqiang Huang
Journal:  Oncotarget       Date:  2016-12-13

4.  Na+/K+-ATPase α1 subunit, a novel therapeutic target for hepatocellular carcinoma.

Authors:  Liping Zhuang; Litao Xu; Peng Wang; Yan Jiang; Pan Yong; Chenyue Zhang; Haibin Zhang; Zhiqiang Meng; Peiying Yang
Journal:  Oncotarget       Date:  2015-09-29

5.  Vitamin D derivatives potentiate the anticancer and anti-angiogenic activity of tyrosine kinase inhibitors in combination with cytostatic drugs in an A549 non-small cell lung cancer model.

Authors:  Ewa Maj; Beata Filip-Psurska; Magdalena Milczarek; Mateusz Psurski; Andrzej Kutner; Joanna Wietrzyk
Journal:  Int J Oncol       Date:  2017-12-15       Impact factor: 5.650

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.